Adjuvant Therapy Questioned for Patients With Small Pancreatic Tumors

Newsfeed Image, Light Gray Text On Dark Gray Background
Patients with early stage pancreatic ductal adenocarcinoma (PDAC) may not benefit from adjuvant therapy after surgery if the tumor is smaller than 1 cm, according to a retrospective analysis published in Cancer.

Although the study indicates a change in the standard of care may be necessary for patients with particularly small tumors, additional studies are needed to validate the findings. Read more . . .